Dr Sarah Weiland Holland, MD | |
74 Gray Rd Ste 1b, Falmouth, ME 04105-2062 | |
(207) 835-4779 | |
(207) 835-4779 |
Full Name | Dr Sarah Weiland Holland |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 74 Gray Rd Ste 1b, Falmouth, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144247735 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 017166 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sarah Weiland Holland, MD 74 Gray Road, Suite 1b, Falmouth, ME 04105 Ph: (207) 835-0477 | Dr Sarah Weiland Holland, MD 74 Gray Rd Ste 1b, Falmouth, ME 04105-2062 Ph: (207) 835-4779 |
News Archive
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced interim clinical results for the company's two lead product candidates, an intravenous recombinant porcine FVIII (OBI-1) in the treatment of serious bleeds in acquired hemophilia A (AHA) and an intravenous recombinant FIX (IB1001) for the treatment and prevention of bleeding in children less than 12 years of age with hemophilia B.
Two professors at The University of Texas Health Science Center at Houston - Barry Davis, M.D., Ph.D., and Kevin Morano, Ph.D. - have been elected fellows into the American Association for the Advancement of Science, the world's largest general scientific society and publisher of the journal Science.
Rush University Medical Center is sponsoring a Nutritional Medicine workshop March 15 to 16, 2012, that features internationally-renowned faculty who are leaders in research in nutritional medicine.
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. The results offer a bit of good news in efforts to develop a therapy to stop or slow the progression of a disease that generally kills its victims within just a few years.
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three- and nine-month periods ended September 30, 2010.
› Verified 4 days ago